XML 25 R13.htm IDEA: XBRL DOCUMENT

CASH FLOW INFORMATION

6 Months Ended

Jun. 30, 2025

CASH FLOW INFORMATION

CASH FLOW INFORMATION

4 – CASH FLOW INFORMATION

For the six months ended June 30, 2025, the Company had non-cash investing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expenses consisting of $1,631 for the Purchase of vessels and ballast water treatment systems, including deposits, and $119 for the Purchase of other fixed assets. For the six months ended June 30, 2025, the Company had non-cash financing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expense consisting of $1,571 for Cash dividends payable and $182 for the Payment of deferred financing costs.

For the six months ended June 30, 2024, the Company had non-cash investing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expenses consisting of $702 for the Purchase of vessels and ballast water treatment systems, including deposits, $373 for the Purchase of other fixed assets, $39 for Vessels held for sale and $75 for the Net proceeds from sale of vessels. For the six months ended June 30, 2024, the Company had non-cash financing activities not included in the Condensed Consolidated Statement of Cash Flows for items included in Accounts payable and accrued expense consisting of $1,230 for Cash dividends payable.

During the six months ended June 30, 2025 and 2024, cash paid for interest was $4,130 and $7,071, respectively, which was offset by $0 and $588 received as result of the interest rate cap agreements, respectively.

During the six months ended June 30, 2025 and 2024, any cash paid for income taxes was insignificant.

All stock options exercised during the six months ended June 30, 2025 and 2024 were cashless. Refer to Note 14 — Stock-Based Compensation for further information.

On May 20, 2025, the Company granted 59,136 restricted stock units to certain members of the Board of Directors. The aggregate fair value of these restricted stock units was $825.

On February 18, 2025, the Company granted 267,344 restricted stock units and 145,792 performance-based restricted stock units to certain individuals. The aggregate fair value of these restricted stock units and performance-based restricted stock units was $3,970 and $2,479, respectively.

On May 23, 2024, the Company granted 38,122 restricted stock units to certain members of the Board of Directors. The aggregate fair value of these restricted stock units was $825.

On February 21, 2024, the Company granted 168,411 restricted stock units and 99,065 performance-based restricted stock units to certain individuals. The aggregate fair value of these restricted stock units and performance-based restricted stock units was $3,060 and $2,143, respectively.

Refer to Note 14 — Stock-Based Compensation for further information regarding the aforementioned grants.

Supplemental Condensed Consolidated Cash Flow information related to leases is as follows:


		For the Six Months Ended
		June 30,
		2025			2024
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases		$	1,226		$	1,226